Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVanquis Banking Regulatory News (VANQ)

Share Price Information for Vanquis Banking (VANQ)

Share Price is delayed by 15 minutes
Get Live Data
107.40    0.20 (0.19%)
Bid:
107.60
Ask:
108.00
Spread: 0.40 (0.372%)
Market Cap: £268.86m
VANQ Live PriceLast checked at - London Stock Exchange

Intraday Vanquis Banking Share Chart

Tender Offer Final Results

1 Oct 2025 09:14

RNS Number : 6002B
Vanquis Banking Group PLC
01 October 2025
 

NOT FOR DISTRIBUTION IN OR INTO OR TO ANY PERSON LOCATED OR RESIDENT IN THE UNITED STATES OF AMERICA, ITS TERRITORIES AND POSSESSIONS (INCLUDING PUERTO RICO, THE U.S. VIRGIN ISLANDS, GUAM, AMERICAN SAMOA, WAKE ISLAND AND THE NORTHERN MARIANA ISLANDS), ANY STATE OF THE UNITED STATES AND THE DISTRICT OF COLUMBIA (THE "UNITED STATES") OR TO ANY U.S. PERSON (AS DEFINED IN THE TENDER OFFER MEMORANDUM) OR IN OR INTO ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO DISTRIBUTE THIS ANNOUNCEMENT.

1 October 2025

VANQUIS BANKING GROUP PLC ANNOUNCES FINAL RESULTS OF THE TENDER OFFER

 

On 23 September 2025, Vanquis Banking Group plc (the "Company") launched an invitation to holders of its outstanding £200,000,000 Fixed Rate Reset Subordinated Tier 2 Notes due 2032 (ISIN: XS2397348801) (the "Notes"), to tender such Notes for purchase by the Company for cash (such invitation the "Offer"). The Offer was made on the terms and subject to the conditions contained in the tender offer memorandum dated 23 September 2025 (the "Tender Offer Memorandum") and was subject to the offer restrictions more fully described in the Tender Offer Memorandum. Capitalised terms used and not otherwise defined in this announcement have the meanings given in the Tender Offer Memorandum.

On 23 September 2025, the Company announced that the indicative Maximum Acceptance Amount in relation to the Offer is £60,000,000. The Company today announces that it intends (subject to satisfaction or waiver of the New Financing Condition) to accept all validly tendered Notes pursuant to the Offer for purchase in cash as set out in the table below. The final Maximum Acceptance Amount is £58,464,000.

The Expiration Deadline for the Offer was 4.00 p.m. (London time) on 30 September 2025. The final results of the Offer as at the Expiration Deadline are as follows: 

Description of Notes

Optional Redemption Date of the Notes

Outstanding Principal Amount (prior to completion of the Offer)

Purchase Price

Aggregate Principal Amount Tendered

Pro-ration factor(if any and subject to adjustments, as applicable)

Aggregate Principal Amount of Notes accepted for purchase by the Company

£200,000,000 Fixed Rate Reset Subordinated Tier 2 Notes due 2032

Any day from (and including) 13 October 2026 to (and including) 13 January 2027

£200,000,000

 

100.50 per cent.

 

£58,464,000

N/A

£58,464,000

The Offer remains subject to the conditions and restrictions set out in the Tender Offer Memorandum.

Whether the Company will purchase any Notes validly tendered in the Offer is subject, without limitation, to the satisfaction or waiver of the New Financing Condition. Settlement of the issue of the New Notes is expected to take place today, 1 October 2025 and the New Financing Condition will be satisfied following such settlement.

Subject to the satisfaction or waiver of the New Financing Condition, the expected Tender Offer Settlement Date is 2 October 2025, after which £141,536,000 in aggregate principal amount of Notes will remain outstanding.

All Notes repurchased pursuant to the Offer will be cancelled.

Full details concerning the Offer are set out in the Tender Offer Memorandum.

Morgan Stanley & Co. International plc (Telephone: +44 (0) 20 7677 5040; Email: liabilitymanagementeurope@morganstanley.com; Attention: Attention: Liability Management Team, Global Capital Markets) is acting as Sole Dealer Manager. Kroll Issuer Services Limited (Telephone: +44 20 7704 0880; Email: vanquis@is.kroll.com; Attention: Scott Boswell; Website: https://deals.is.kroll.com/vanquis) is acting as Tender Agent.

THIS ANNOUNCEMENT RELATES TO THE DISCLOSURE OF INFORMATION THAT QUALIFIED OR MAY HAVE QUALIFIED AS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE MARKET ABUSE REGULATION (EU) 596/2014 AS IT FORMS PART OF DOMESTIC LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018 (THE "EUWA") ("UK MAR").

FOR THE PURPOSES OF UK MAR AND ARTICLE 2 OF COMMISSION IMPLEMENTING REGULATION (EU) 2016/1055 AS IT FORMS PART OF DOMESTIC LAW BY VIRTUE OF THE EUWA, THIS ANNOUNCEMENT IS MADE BY DAVID WATTS, DIRECTOR OF VANQUIS BANKING GROUP PLC.

Legal Entity Identifier: 213800U93SZC44VXN635

 

DISCLAIMER This announcement must be read in conjunction with the Tender Offer Memorandum. No offer or invitation to acquire or sell any securities is being made pursuant to this announcement. The Sole Dealer Manager does not take responsibility for the contents of this announcement. The distribution of this announcement and the Tender Offer Memorandum in certain jurisdictions may be restricted by law. Persons into whose possession this announcement and/or the Tender Offer Memorandum come into are required by each of the Company, the Sole Dealer Manager and the Tender Agent to inform themselves about, and to observe, any such restrictions.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TENVFLBBEBLBFBV
Date   Source Headline
10th Jun 20269:53 amRNSHolding(s) in Company
29th May 20264:00 pmRNSTotal Voting Rights
29th May 20269:12 amRNSHolding(s) in Company
28th May 20261:37 pmRNSHolding(s) in Company
28th May 20268:39 amRNSHolding(s) in Company
22nd May 20269:00 amRNSTender Offer Final Results
21st May 20269:04 amRNSHolding(s) in Company
19th May 20263:15 pmRNSPublication of Offering Circular
15th May 20264:00 pmRNSDirector/PDMR Shareholding
14th May 20262:58 pmRNSTender Offer - Maximum Acceptance
14th May 20269:18 amRNSTender Offer
6th May 202611:13 amRNSResult of AGM
6th May 20267:00 amRNS1st Quarter Results
30th Apr 20264:30 pmRNSTotal Voting Rights
27th Apr 20267:00 amRNSMotor Finance Redress Schemes Update
15th Apr 20264:30 pmRNSDirector/PDMR Shareholding
8th Apr 202611:00 amRNSDirector/PDMR Shareholding
31st Mar 20264:30 pmRNSTotal Voting Rights
18th Mar 20264:30 pmRNSDirector/PDMR Shareholding
16th Mar 20264:30 pmRNSNon-Executive Director Pension Transfer
4th Mar 20269:18 amRNSDirector/PDMR Shareholding
27th Feb 20264:34 pmRNSHolding(s) in Company
27th Feb 20264:30 pmRNSTotal Voting Rights
26th Feb 20267:00 amRNSPublication of Annual Report and AGM Notice
26th Feb 20267:00 amRNSResults for the year ended 31 December 2025
17th Feb 20264:30 pmRNSDirector/PDMR Shareholding
17th Feb 20263:54 pmRNSHolding(s) in Company
10th Feb 20263:33 pmRNSHolding(s) in Company
4th Feb 20264:32 pmRNSNotice of FY 2025 Results & Investor Presentations
30th Jan 20264:30 pmRNSTotal Voting Rights
30th Jan 20263:56 pmRNSHolding(s) in Company
23rd Jan 202612:40 pmRNSHolding(s) in Company
16th Jan 20262:55 pmRNSHolding(s) in Company
15th Jan 20264:30 pmRNSDirector/PDMR Shareholding
15th Jan 20263:02 pmRNSBlock listing Interim Review
8th Jan 20265:20 pmRNSHolding(s) in Company
31st Dec 20251:00 pmRNSTotal Voting Rights
31st Dec 20251:00 pmRNSTotal Voting Rights
16th Dec 20254:00 pmRNSDirector/PDMR Shareholding
9th Dec 20251:11 pmRNSHolding(s) in Company
8th Dec 20254:28 pmRNSHolding(s) in Company
5th Dec 20251:34 pmRNSHolding(s) in Company
28th Nov 20254:30 pmRNSTotal Voting Rights
24th Nov 20257:00 amRNSChange of Corporate Brokers
17th Nov 202512:44 pmRNSDirector/PDMR Shareholding
13th Nov 20253:09 pmRNSDirector/PDMR Shareholding
5th Nov 20257:00 amRNS3rd Quarter Trading Statement
31st Oct 20254:30 pmRNSTotal Voting Rights
16th Oct 20254:00 pmRNSDirector/PDMR Shareholding
13th Oct 20258:30 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.